OpenAlex
PricingAboutJobs
Log inGet started
Work

Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study

HTML

Year: 2013
Type: article
Study design: Clinical Trial
Source: European Journal of Cancer
DOI: 10.1016/j.ejca.2013.11.002
Authors: Reinhard Dummer, Simone M. Goldinger, Christian P. Turtschi, Nina B. Eggmann, Olivier Michielin, Lada Mitchell, Luisa Veronese, Paul René Hilfiker, Lea Felderer, Jeannine D. Rinderknecht
Institutions: University Hospital Zurich, University of Lausanne, F. Hoffmann-La Roche AG
Language: English

Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: vemurafenib, BRAF V600 mutation, melanoma, brain metastases, BRAF inhibitors, treatment safety, adverse events, cutaneous squamous cell carcinoma, progression-free survival, overall survival, partial response
SDG: Good health and well-being

Open Access status: closed

Funders: F. Hoffmann-La Roche, European Society for Medical Oncology
OpenAlex ID: W2006741643
FWCI: 13.71
Cites: 28
Cited by: 304
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms